mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
9e-09 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.39 |
2e-08 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
7e-08 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.29 |
8e-08 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.37 |
1e-07 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-07 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
5e-07 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
5e-07 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
5e-07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
5e-07 |